KORRO BIO INC (KRRO) Stock Balance Sheet
NASDAQ:KRRO - Nasdaq - US5009461089 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 64.14M | 55.64M | 166.15M | 51.95M | 79.64M | |||
| Marketable Securities | 50.81M | 70.45M | 0.00 | 18.91M | 35.04M | |||
| Receivables | 1.92M | 1.70M | N/A | 449.00K | 144.00K | |||
| Other Current Assets | 4.36M | 3.74M | 6.58M | 1.83M | 1.43M | |||
| Total Current Assets | 121.23M | 131.53M | 172.73M | 57.08M | 119.78M | |||
| Non-Current Assets | ||||||||
| PPE Net | 50.35M | 51.55M | 42.81M | 11.89M | 6.45M | |||
| Investments And Advances | 24.04M | 36.96M | N/A | 0.00 | 11.72M | |||
| Other Non-Current Assets | 6.58M | 6.20M | 6.12M | 4.77M | 1.35M | |||
| Total Non-Current Assets | 80.97M | 94.71M | 48.94M | 16.66M | 7.80M | |||
| TOTAL ASSETS | 202.21M | 226.24M | 221.66M | 73.74M | 127.58M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 10.00M | 833.00K | |||
| Accrued Expenses | 5.46M | 7.18M | 11.36M | 5.89M | 401.00K | |||
| Accounts Payable | 4.18M | 3.99M | 7.28M | 2.60M | 789.00K | |||
| Other Current Liabilities | 3.24M | 3.79M | 842.00K | 207.00K | 3.76M | |||
| Total Current Liabilities | 12.88M | 14.96M | 19.48M | 8.70M | 4.95M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 50.37M | 50.87M | 32.27M | 209.00K | 971.00K | |||
| Total Non-Current Liabilities | 50.37M | 50.87M | 32.27M | 209.00K | 971.00K | |||
| TOTAL LIABILITIES | 63.25M | 65.83M | 51.75M | 8.91M | 5.92M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -289.97M | -266.59M | -183.00M | -101.83M | -43.80M | |||
| Additional Paid In Capital | 428.66M | 426.72M | 352.91M | 2.81M | 1.59M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 9.00K | 9.00K | 8.00K | 163.86M | 163.87M | |||
| Other Shareholders' Equity | 264.00K | 268.00K | 0.00 | -5.00K | -7.00K | |||
| Shares Outstanding | 9.39M | 9.38M | 8.02M | 8.00M | 8.00M | |||
| Tangible Book Value per Share | 14.80 | 17.11 | 21.20 | -12.38 | -5.28 | |||
| Total Shareholders' Equity | 138.96M | 160.41M | 169.91M | 64.83M | 121.66M | |||
| TOTAL LIABILITIES AND EQUITY | 202.21M | 226.24M | 221.66M | 73.74M | 127.58M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 9.41 | 8.79 | 8.87 | 6.56 | 24.20 | |||
| Return On Assets (ROA) | -43.23% | -36.94% | -36.62% | -78.70% | -17.21% | |||
| Return On Equity (ROE) | -62.91% | -52.10% | -47.77% | -89.51% | -18.05% | |||
All data in USD , ROIC based on taxRate of 0.21